|
[1] HE FL,WANG L,YUE ZD,et al. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients[J]. World J Gastroenterol,2014,20(33):11835-11839.
|
|
[2] YU ZG,LIN YH,HUANG WF,et al. Clinical efficacy and safety of different endoscopy methods in patients with liver cirrhosis complicated with esophagogastric varicosity bleeding[J]. J Clin Exp Med,2018,17(8):813-816.(in Chinese)余中贵，林燕华，黄文峰，等．不同内镜方案对肝硬化合并食管胃底静脉曲张破裂出血患者临床疗效及安全性分析[J]．临床和实验医学杂志，2018,17(8):813-816.
|
|
[3] GARCIA-TG,ABRALDES JG,BERZIGOTTI A,et al. Portal hypertensive bleeding in cirrhosis:Risk stratification,diagnosis,and management:2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology,2017,65(1):310-335.
|
|
[4] PAPATHEODORIDIS GV,GOULIS J,LEANDRO G,et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding:A metaanalysis[J]. Hepatology,1999,30(3):612-622.
|
|
[5] Portal hypertension group of Chinese Surgery Branch. Consensus diagnosis and treatment of cirrhotic portal hypertension with esophageal and gastric varices bleeding(2015 edition)[J]. Chin J Gen Surg,2016,31(2):167-170.(in Chinese)中华外科学分会门静脉高压症学组．肝硬化门静脉高压症食管胃底静脉曲张破裂出血的诊治共识(2015版)[J]．中华普通外科杂志，2016,31(2):167-170.
|
|
[6] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. J Clin Hepatol,2018,34(10):2076-2089.(in Chinese)中华医学会肝病学分会．肝硬化肝性脑病诊疗指南[J]．临床肝胆病杂志，2018,34(10):2076-2089.
|
|
[7] MASSON S,MARDINI HA,ROSE JD,et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion:A decade of experience[J]. QJM,2008,101(6):493-501.
|
|
[8] Chinese Portal Hypertension Diagnosis and Monitoring Study Group(CHESS); Minimally Invasive Intervention Collaborative Group,Chinese Society of Gastroenterology; Emergency Intervention Committee,Chinese College of Interventionalists,et al. Consensus on clinical application of hepatic venous pressure gradient in China(2018)[J]. J Clin Hepatol,2018,34(12):2526-2536.(in Chinese)中国门静脉高压诊断与监测研究组(CHESS)，中华医学会消化病学分会微创介入协作组，中国医师协会介入医师分会急诊介入专业委员会，等．中国肝静脉压力梯度临床应用专家共识(2018版)[J]．临床肝胆病杂志，2018,34(12):2526-2536.
|
|
[9] LU W,YANG C,ZHANG JC,et al. The effect of wedged hepatic venography with CO2during TIPS in the treatment of acute upper gastro-intestinal bleeding in liver cirrhosis[J].China Med Herald,2019,16(10):84-87.(in Chinese)卢伟，杨超，张嘉诚，等．CO2楔入肝静脉造影在肝硬化急性上消化道出血的TIPS术中的作用[J]．中国医药导报，2019,16(10):84-87.
|
|
[10] LYU Y,ZUO L,ZHU X,et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding:A multicentre observational study[J]. Gut,2019,68(7):1297-1310.
|
|
[11] SIRAMOLPIWAT S. Transjugular intrahepatic portosystemic shunts and portal hypertension related complications[J]. World J Gastroenterol,2014,20(45):16996-17010.
|
|
[12] FERENCI P,LOCKWOOD A,MULLEN K,et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification:Final report of the working party at the 11th World Congresses of Gastroenterology[J]. Hepatology,2002,35(3):716-721.
|
|
[13] ABRALDES JG,TANDON P. Therapies:Drugs,scopes and transjugular intrahepatic portosystemic shunt--when and how?[J]. Dig Dis,2015,33(4):524-533.
|
|
[14] MENDEZ M,MENDEZ-LOPEZ M,LOPEZ L,et al. Portosystemic hepatic encephalopathy model shows reversal learning impairment and dysfunction of neural activity in the prefrontal cortex and regions involved in motivated behavior[J]. J Clin Neurosci,2011,18(5):690-694.
|
|
[15] LUO X,ZHAO M,WANG X,et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft[J]. PLo S One,2019,14(2):e0212658.
|
|
[16] RIGGIO O,NARDELLI S,MOSCUCCI F,et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Clin Liver Dis,2012,16(1):133-146.
|
|
[17] PEREIRA K,CARRION AF,MARTIN P,et al. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy[J]. Liver Int,2015,35(12):2487-2494.
|
|
[18] AHMED R,SANTHANAM P,RAYYAN Y. MELD-Na as a prognostic indicator of 30-and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt[J]. Eur J Gastroenterol Hepatol,2015,27(10):1226-1227.
|
|
[19] LUCIDI C,LATTANZI B,RIGGIO O,et al. May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?[J]. J Hepatol,2018,68(6):1324-1325.
|
|
[20] MALINCHOC M,KAMATH PS,GORDON FD,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology,2000,31(4):864-871.
|
|
[21] NARDELLI S,GIOIA S,PASQUALE C,et al. Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Am J Gastroenterol,2016,111(4):523-528.
|
|
[22] KIM TY,LEE JG,SOHN JH,et al. Hepatic venous pressure gradient predicts long-term mortality in patients with decompensated cirrhosis[J]. Yonsei Med J,2016,57(1):138-145.
|
|
[23] AMESUR NB,NOVELLI P. Transjugular intrahepatic portosystemic shunt[M]. Stat Pearls. Treasure Island(FL):Stat Pearls Publishing,2019.
|
|
[24] ZIVON AS,CHEN L,KAUFMAN J,et al. The degree in reduction of portal-systemic gradient during tips and not final post-tips portal pressure gradient is predictive of the development of hepatic encephalopathy[J]. Gastroenterology,2014,1461(5):s932.
|
|
[25] CHUNG HH,RAZAVI MK,SZE DY,et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft:What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?[J]. J Gastroenterol Hepatol,2008,23(1):95-101.
|
DownLoad: